author_facet Karas, John A.
Chen, Fan
Schneider‐Futschik, Elena K.
Kang, Zhisen
Hussein, Maytham
Swarbrick, James
Hoyer, Daniel
Giltrap, Andrew M.
Payne, Richard J.
Li, Jian
Velkov, Tony
Karas, John A.
Chen, Fan
Schneider‐Futschik, Elena K.
Kang, Zhisen
Hussein, Maytham
Swarbrick, James
Hoyer, Daniel
Giltrap, Andrew M.
Payne, Richard J.
Li, Jian
Velkov, Tony
author Karas, John A.
Chen, Fan
Schneider‐Futschik, Elena K.
Kang, Zhisen
Hussein, Maytham
Swarbrick, James
Hoyer, Daniel
Giltrap, Andrew M.
Payne, Richard J.
Li, Jian
Velkov, Tony
spellingShingle Karas, John A.
Chen, Fan
Schneider‐Futschik, Elena K.
Kang, Zhisen
Hussein, Maytham
Swarbrick, James
Hoyer, Daniel
Giltrap, Andrew M.
Payne, Richard J.
Li, Jian
Velkov, Tony
Annals of the New York Academy of Sciences
Synthesis and structure−activity relationships of teixobactin
History and Philosophy of Science
General Biochemistry, Genetics and Molecular Biology
General Neuroscience
author_sort karas, john a.
spelling Karas, John A. Chen, Fan Schneider‐Futschik, Elena K. Kang, Zhisen Hussein, Maytham Swarbrick, James Hoyer, Daniel Giltrap, Andrew M. Payne, Richard J. Li, Jian Velkov, Tony 0077-8923 1749-6632 Wiley History and Philosophy of Science General Biochemistry, Genetics and Molecular Biology General Neuroscience http://dx.doi.org/10.1111/nyas.14282 <jats:title>Abstract</jats:title><jats:p>The discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial activity against several Gram positive pathogens, including methicillin‐resistant <jats:italic>Staphylococcus aureus</jats:italic> and vancomycin‐resistant <jats:italic>Enterococci</jats:italic>. One of the key features of teixobactin as an antibiotic lead is that resistance could not be generated in a laboratory setting. This is proposed to be a result of a mechanism of action that involves binding to essential cell wall synthesis building blocks, lipid II and lipid III. Since the initial isolation report in 2015, significant efforts have been made to understand its unique mechanism of action, develop efficient synthetic routes for its production, and thus enable the generation of analogues for structure−activity relationship studies and optimization of its pharmacological properties. Our review provides a comprehensive treatise on the progress in understanding teixobactin chemistry, structure−activity relationships, and mechanisms of antibacterial activity. Teixobactin represents an exciting starting point for the development of new antibiotics that can be used to combat multidrug‐resistant bacterial (“superbug”) infections.</jats:p> Synthesis and structure−activity relationships of teixobactin Annals of the New York Academy of Sciences
doi_str_mv 10.1111/nyas.14282
facet_avail Online
finc_class_facet Geschichte
Philosophie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9ueWFzLjE0Mjgy
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9ueWFzLjE0Mjgy
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
issn 0077-8923
1749-6632
issn_str_mv 0077-8923
1749-6632
language English
mega_collection Wiley (CrossRef)
match_str karas2020synthesisandstructureactivityrelationshipsofteixobactin
publishDateSort 2020
publisher Wiley
recordtype ai
record_format ai
series Annals of the New York Academy of Sciences
source_id 49
title Synthesis and structure−activity relationships of teixobactin
title_unstemmed Synthesis and structure−activity relationships of teixobactin
title_full Synthesis and structure−activity relationships of teixobactin
title_fullStr Synthesis and structure−activity relationships of teixobactin
title_full_unstemmed Synthesis and structure−activity relationships of teixobactin
title_short Synthesis and structure−activity relationships of teixobactin
title_sort synthesis and structure−activity relationships of teixobactin
topic History and Philosophy of Science
General Biochemistry, Genetics and Molecular Biology
General Neuroscience
url http://dx.doi.org/10.1111/nyas.14282
publishDate 2020
physical 86-105
description <jats:title>Abstract</jats:title><jats:p>The discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial activity against several Gram positive pathogens, including methicillin‐resistant <jats:italic>Staphylococcus aureus</jats:italic> and vancomycin‐resistant <jats:italic>Enterococci</jats:italic>. One of the key features of teixobactin as an antibiotic lead is that resistance could not be generated in a laboratory setting. This is proposed to be a result of a mechanism of action that involves binding to essential cell wall synthesis building blocks, lipid II and lipid III. Since the initial isolation report in 2015, significant efforts have been made to understand its unique mechanism of action, develop efficient synthetic routes for its production, and thus enable the generation of analogues for structure−activity relationship studies and optimization of its pharmacological properties. Our review provides a comprehensive treatise on the progress in understanding teixobactin chemistry, structure−activity relationships, and mechanisms of antibacterial activity. Teixobactin represents an exciting starting point for the development of new antibiotics that can be used to combat multidrug‐resistant bacterial (“superbug”) infections.</jats:p>
container_issue 1
container_start_page 86
container_title Annals of the New York Academy of Sciences
container_volume 1459
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341191796195329
geogr_code not assigned
last_indexed 2024-03-01T16:16:00.583Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Synthesis+and+structure%E2%88%92activity+relationships+of+teixobactin&rft.date=2020-01-01&genre=article&issn=1749-6632&volume=1459&issue=1&spage=86&epage=105&pages=86-105&jtitle=Annals+of+the+New+York+Academy+of+Sciences&atitle=Synthesis+and+structure%E2%88%92activity+relationships+of+teixobactin&aulast=Velkov&aufirst=Tony&rft_id=info%3Adoi%2F10.1111%2Fnyas.14282&rft.language%5B0%5D=eng
SOLR
_version_ 1792341191796195329
author Karas, John A., Chen, Fan, Schneider‐Futschik, Elena K., Kang, Zhisen, Hussein, Maytham, Swarbrick, James, Hoyer, Daniel, Giltrap, Andrew M., Payne, Richard J., Li, Jian, Velkov, Tony
author_facet Karas, John A., Chen, Fan, Schneider‐Futschik, Elena K., Kang, Zhisen, Hussein, Maytham, Swarbrick, James, Hoyer, Daniel, Giltrap, Andrew M., Payne, Richard J., Li, Jian, Velkov, Tony, Karas, John A., Chen, Fan, Schneider‐Futschik, Elena K., Kang, Zhisen, Hussein, Maytham, Swarbrick, James, Hoyer, Daniel, Giltrap, Andrew M., Payne, Richard J., Li, Jian, Velkov, Tony
author_sort karas, john a.
container_issue 1
container_start_page 86
container_title Annals of the New York Academy of Sciences
container_volume 1459
description <jats:title>Abstract</jats:title><jats:p>The discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial activity against several Gram positive pathogens, including methicillin‐resistant <jats:italic>Staphylococcus aureus</jats:italic> and vancomycin‐resistant <jats:italic>Enterococci</jats:italic>. One of the key features of teixobactin as an antibiotic lead is that resistance could not be generated in a laboratory setting. This is proposed to be a result of a mechanism of action that involves binding to essential cell wall synthesis building blocks, lipid II and lipid III. Since the initial isolation report in 2015, significant efforts have been made to understand its unique mechanism of action, develop efficient synthetic routes for its production, and thus enable the generation of analogues for structure−activity relationship studies and optimization of its pharmacological properties. Our review provides a comprehensive treatise on the progress in understanding teixobactin chemistry, structure−activity relationships, and mechanisms of antibacterial activity. Teixobactin represents an exciting starting point for the development of new antibiotics that can be used to combat multidrug‐resistant bacterial (“superbug”) infections.</jats:p>
doi_str_mv 10.1111/nyas.14282
facet_avail Online
finc_class_facet Geschichte, Philosophie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9ueWFzLjE0Mjgy
imprint Wiley, 2020
imprint_str_mv Wiley, 2020
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161
issn 0077-8923, 1749-6632
issn_str_mv 0077-8923, 1749-6632
language English
last_indexed 2024-03-01T16:16:00.583Z
match_str karas2020synthesisandstructureactivityrelationshipsofteixobactin
mega_collection Wiley (CrossRef)
physical 86-105
publishDate 2020
publishDateSort 2020
publisher Wiley
record_format ai
recordtype ai
series Annals of the New York Academy of Sciences
source_id 49
spelling Karas, John A. Chen, Fan Schneider‐Futschik, Elena K. Kang, Zhisen Hussein, Maytham Swarbrick, James Hoyer, Daniel Giltrap, Andrew M. Payne, Richard J. Li, Jian Velkov, Tony 0077-8923 1749-6632 Wiley History and Philosophy of Science General Biochemistry, Genetics and Molecular Biology General Neuroscience http://dx.doi.org/10.1111/nyas.14282 <jats:title>Abstract</jats:title><jats:p>The discovery of antibiotics has led to the effective treatment of bacterial infections that were otherwise fatal and has had a transformative effect on modern medicine. Teixobactin is an unusual depsipeptide natural product that was recently discovered from a previously unculturable soil bacterium and found to possess potent antibacterial activity against several Gram positive pathogens, including methicillin‐resistant <jats:italic>Staphylococcus aureus</jats:italic> and vancomycin‐resistant <jats:italic>Enterococci</jats:italic>. One of the key features of teixobactin as an antibiotic lead is that resistance could not be generated in a laboratory setting. This is proposed to be a result of a mechanism of action that involves binding to essential cell wall synthesis building blocks, lipid II and lipid III. Since the initial isolation report in 2015, significant efforts have been made to understand its unique mechanism of action, develop efficient synthetic routes for its production, and thus enable the generation of analogues for structure−activity relationship studies and optimization of its pharmacological properties. Our review provides a comprehensive treatise on the progress in understanding teixobactin chemistry, structure−activity relationships, and mechanisms of antibacterial activity. Teixobactin represents an exciting starting point for the development of new antibiotics that can be used to combat multidrug‐resistant bacterial (“superbug”) infections.</jats:p> Synthesis and structure−activity relationships of teixobactin Annals of the New York Academy of Sciences
spellingShingle Karas, John A., Chen, Fan, Schneider‐Futschik, Elena K., Kang, Zhisen, Hussein, Maytham, Swarbrick, James, Hoyer, Daniel, Giltrap, Andrew M., Payne, Richard J., Li, Jian, Velkov, Tony, Annals of the New York Academy of Sciences, Synthesis and structure−activity relationships of teixobactin, History and Philosophy of Science, General Biochemistry, Genetics and Molecular Biology, General Neuroscience
title Synthesis and structure−activity relationships of teixobactin
title_full Synthesis and structure−activity relationships of teixobactin
title_fullStr Synthesis and structure−activity relationships of teixobactin
title_full_unstemmed Synthesis and structure−activity relationships of teixobactin
title_short Synthesis and structure−activity relationships of teixobactin
title_sort synthesis and structure−activity relationships of teixobactin
title_unstemmed Synthesis and structure−activity relationships of teixobactin
topic History and Philosophy of Science, General Biochemistry, Genetics and Molecular Biology, General Neuroscience
url http://dx.doi.org/10.1111/nyas.14282